270
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart Review

, MD, , MD, PhD, , MD, , MD, , MD & , MD, MPH
Pages 566-571 | Received 16 Nov 2018, Accepted 28 Oct 2019, Published online: 19 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Matthew Driban, Nikita Kedia, Supriya Arora & Jay Chhablani. (2023) Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders. Expert Review of Clinical Pharmacology 16:11, pages 1125-1139.
Read now
Lingling Huang, Christina Flaxel, Eric Suhler & Phoebe Lin. (2023) Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha. Ocular Immunology and Inflammation 0:0, pages 1-10.
Read now
L. De Simone, P. Gentile, R. Aldigeri, V. Mastrofilippo, E. Bolletta, F. Gozzi, C. Adani, C. Salvarani & L. Cimino. (2023) Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now
Nihan Aksu-Ceylan, Zafer Cebeci, Emre Altinkurt, Nur Kir, Merih Oray & Ilknur Tugal-Tutkun. (2022) Interferon Alpha-2a for the Treatment of Cystoid Macular Edema Secondary to Acute Retinal Necrosis. Ocular Immunology and Inflammation 30:7-8, pages 1788-1797.
Read now

Articles from other publishers (4)

Jie Zhang, Hui YanJing LiBing Li. (2022) Aqueous Humor Factors' Predictive Effects in Treating Refractor Macular Edema: An Overview. Journal of Interferon & Cytokine Research 42:10, pages 515-524.
Crossref
. (2022) Multiple drugs. Reactions Weekly 1894:1, pages 247-247.
Crossref
Lisia Barros Ferreira, Anthony J. SmithJustine R. Smith. (2021) Biologic Drugs for the Treatment of Noninfectious Uveitis. Asia-Pacific Journal of Ophthalmology 10:1, pages 63-73.
Crossref
. (2017) Peginterferon-α-2a. Reactions Weekly 1654:1, pages 277-277.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.